nabriva therapeutics plc

Public Company

Company Profile

Sector: Health Care
Industry: Biotech & Pharma
Sub-Industry: Specialty Pharma
Nabriva Therapeutics Plc operates as a clinical-stage biopharmaceutical company. The Company researches and develops intravenous (IV) and oral formulations of lefamulin for the treatment of community-acquired bacterial pneumonia (CABP). Nabriva Therapeutics serves patients in worldwide.

Corporate Information

56 Fitzwilliam Square
Dublin, 2
Fax: -
Web url:

From The Web

Sponsored Financial Commentaries

More From The Web